Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma

NCT06436677 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06436677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06436677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 9, 2024
Completion date
December 31, 2030
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous t cell lymphoma, cutaneous t-cell lymphoma/mycosis fungoides